This week, this drug is getting some attention, and that's because former Republican Senator Ben Sass telling the New York Times that he's been taking an experimental drug to treat the stage 4 pancreatic cancer that he was diagnosed with late last year. And he called that at the time a death sentence. And now he's bringing attention to this diagnosis.So, pancreatic cancer has the lowest 5-year survival rate of any major cancer. That's just 13%. And that number really hasn't moved despite advances in other c ...

Bayer said its experimental drug cut the risk of secondary strokes by 26% in a late-stage trial, bolstering its prospects of driving growth as it faces pressure from generic competition https://t.co/sdroMJYhC6 ...

Core Insights - aTyr Pharma's experimental drug did not achieve its primary endpoint in a late-stage study for pulmonary sarcoidosis, indicating a setback in its development pipeline [1] Company Summary - The drug was being tested in patients with pulmonary sarcoidosis, a type of lung disease [1] - The failure to meet the main goal suggests potential challenges for aTyr Pharma in advancing this treatment [1]

Clemens Fischer has never smoked pot in his life, but he believes his new experimental drug could reap billions in sales—and change millions of lives. https://t.co/Jo67CiP4Jo (Photo: Clemens Fischer) https://t.co/QGVZb96D5i ...

AstraZeneca’s experimental drug for a rare autoimmune disorder helped patients control their disease, the company says, boosting prospects for the potential blockbuster medicine https://t.co/EXIc325yfT ...

Roche’s experimental drug for a deadly lung condition got mixed results in trials, a setback as the company seeks to accelerate the development of new treatments https://t.co/08IlVIVFXg ...

AstraZeneca’s experimental drug for a rare plasma cell disorder failed to delay deaths or reduce hospitalizations, dimming hopes for treating severe cases https://t.co/GmXb2u6u4I ...